Shares of Pro Medicus (ASX:PME) have emerged as the top gainer on the benchmark ASX 200, having climbed 10.8% to reach a record high of A$78.85.

This significant growth comes after the healthcare imaging software company sealed a massive 10-year contract with Baylor Scott & White Health in Texas.

The value placed on the contract is approximately AUD140 million ($89.89 million).

As of the last close, Pro Medicus (ASX:PME)’s stock has risen by an impressive 28.3% this year, reflecting the company’s positive trajectory.

Pro Medicus (ASX:PME) is a healthcare imaging software company.